Literature DB >> 33061654

Evaluation of Antibiotic Utilization Pattern During Acute Diarrheal Disease at Chefa-Robit Health Center, Kemissie, North East Amhara, Ethiopia.

Desye Misganaw1, Kassaw Abtew1.   

Abstract

BACKGROUND: Despite the fact that the majority of the acute diarrheal diseases are viral in origin and self-limited, routine and injudicious antibiotic treatment is a common practice globally and more prevalent in Africa. Indeed, the irrational use of antibiotics has a detrimental effect on the issue of antibiotics resistance and associated healthcare costs. Accordingly, a health center-based cross-sectional study is mandatory and was conducted due to the common malpractice of antibiotics use.
OBJECTIVE: The aim of this study was to evaluate the antibiotic use pattern in the treatment of acute diarrheal disease in Chefa-robit health center, Kemissie, Northeastern Ethiopia. METHODS AND MATERIALS: A retrospective cross-sectional study was conducted to evaluate the antibiotic utilization pattern for the treatment of acute diarrheal disease. Data was collected from 230 patients' record cards treated for acute diarrheal disease from January 2018 to December 2018 using structured questionnaires. The finding is presented using frequency distribution and percentages in tables as well as figures.
RESULTS: Among the 230 patients, 49.60% were males and the rest were females. From the total, 172 of them were with watery type of diarrhea and 132 of them were prescribed antibiotics inappropriately out of which 77 were under 5 years. In addition, 27 patients were diagnosed with mucoid diarrhea and only eight of them were treated with antibiotics whereas 31 patients were with bloody type of diarrhea and 10 of them were not treated with antibiotics. Of the 230 cases, 161 (70%) patients received different types of antibiotics, and co-trimoxazole, amoxicillin and ciprofloxacin were the most prescribed antibiotics.
CONCLUSION: The study revealed that there is a high level of inappropriate antibiotics use which may fuel the increased antimicrobial resistance and associated costs nationally as well as globally.
© 2020 Misganaw and Abtew.

Entities:  

Keywords:  acute diarrheal disease; antibiotics; antimicrobial resistance

Year:  2020        PMID: 33061654      PMCID: PMC7534044          DOI: 10.2147/DHPS.S256330

Source DB:  PubMed          Journal:  Drug Healthc Patient Saf        ISSN: 1179-1365


  19 in total

1.  Practice guidelines for the management of infectious diarrhea.

Authors:  R L Guerrant; T Van Gilder; T S Steiner; N M Thielman; L Slutsker; R V Tauxe; T Hennessy; P M Griffin; H DuPont; R B Sack; P Tarr; M Neill; I Nachamkin; L B Reller; M T Osterholm; M L Bennish; L K Pickering
Journal:  Clin Infect Dis       Date:  2001-01-30       Impact factor: 9.079

2.  Antibiotic use in developing countries.

Authors:  R E Istúriz; C Carbon
Journal:  Infect Control Hosp Epidemiol       Date:  2000-06       Impact factor: 3.254

3.  Optimal dosing of ofloxacin with loperamide in the treatment of non-dysenteric travelers' diarrhea.

Authors:  C D Ericsson; H L DuPont; J J Mathewson
Journal:  J Travel Med       Date:  2001 Jul-Aug       Impact factor: 8.490

4.  Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea.

Authors:  Joaquim Ruiz; Francesc Marco; Ines Oliveira; Jordi Vila; Joaquim Gascón
Journal:  APMIS       Date:  2007-03       Impact factor: 3.205

5.  World Gastroenterology Organisation Global Guidelines: Celiac Disease February 2017.

Authors:  Julio C Bai; Carolina Ciacci
Journal:  J Clin Gastroenterol       Date:  2017-10       Impact factor: 3.062

Review 6.  Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology.

Authors:  H L DuPont
Journal:  Am J Gastroenterol       Date:  1997-11       Impact factor: 10.864

7.  Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial.

Authors:  C D Ericsson; P C Johnson; H L Dupont; D R Morgan; J A Bitsura; F J de la Cabada
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

8.  Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial.

Authors:  M L Bennish; M A Salam; W A Khan; A M Khan
Journal:  Ann Intern Med       Date:  1992-11-01       Impact factor: 25.391

9.  Use of stool collection kits delivered to patients can improve confirmation of etiology in foodborne disease outbreaks.

Authors:  Timothy F Jones; S N Bulens; S Gettner; R L Garman; D J Vugia; D Blythe; M A Hawkins; S S Monroe; F J Angulo; U D Parashar
Journal:  Clin Infect Dis       Date:  2004-10-25       Impact factor: 9.079

Review 10.  Acute diarrhea: a practical review.

Authors:  J Aranda-Michel; R A Giannella
Journal:  Am J Med       Date:  1999-06       Impact factor: 4.965

View more
  1 in total

1.  Prevalence and drug resistance patterns of Gram-negative enteric bacterial pathogens from diarrheic patients in Ethiopia: A systematic review and meta-analysis.

Authors:  Achenef Melaku Beyene; Mucheye Gezachew; Desalegn Mengesha; Ahmed Yousef; Baye Gelaw
Journal:  PLoS One       Date:  2022-03-16       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.